Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND AND OBJECTIVE: Chronic Low Back Pain (CLBP) is very common, with a lifetime prevalence between 51% and 80%. In majority, it is nonspecific in nature and multifactorial in etiology. Pregabalin (PG) and Gabapentin (GB) are gabapentinoids that have demonstrated benefit in neuropathic pain co...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanthanna, Harsha, Gilron, Ian, Rajarathinam, Manikandan, AlAmri, Rizq, Kamath, Sriganesh, Thabane, Lehana, Devereaux, Philip J., Bhandari, Mohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428/
https://www.ncbi.nlm.nih.gov/pubmed/28809936
http://dx.doi.org/10.1371/journal.pmed.1002369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428/
https://www.ncbi.nlm.nih.gov/pubmed/28809936
http://dx.doi.org/10.1371/journal.pmed.1002369

Ejemplares similares